Carmen Wängler

4.1k total citations · 1 hit paper
127 papers, 3.2k citations indexed

About

Carmen Wängler is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Carmen Wängler has authored 127 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Radiology, Nuclear Medicine and Imaging, 45 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Carmen Wängler's work include Radiopharmaceutical Chemistry and Applications (69 papers), Medical Imaging Techniques and Applications (34 papers) and Peptidase Inhibition and Analysis (26 papers). Carmen Wängler is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (69 papers), Medical Imaging Techniques and Applications (34 papers) and Peptidase Inhibition and Analysis (26 papers). Carmen Wängler collaborates with scholars based in Germany, Canada and United States. Carmen Wängler's co-authors include Björn Wängler, Ralf Schirrmacher, Walter Mier, Michael Eisenhut, Uwe Haberkorn, Martin Schäfer, Matthias Eder, Ulrike Bauder‐Wüst, Esther Schirrmacher and Peter Bartenstein and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Carmen Wängler

120 papers receiving 3.2k citations

Hit Papers

68Ga-Complex Lipophilicity and the Targeting Property of ... 2012 2026 2016 2021 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Wängler Germany 31 2.1k 928 836 812 499 127 3.2k
Ganesan Vaidyanathan United States 37 2.6k 1.3× 1.1k 1.1× 1.0k 1.2× 702 0.9× 298 0.6× 128 3.9k
Björn Wängler Germany 36 2.0k 0.9× 1.3k 1.4× 946 1.1× 403 0.5× 569 1.1× 155 3.9k
D. Scott Wilbur United States 35 2.7k 1.3× 659 0.7× 678 0.8× 645 0.8× 402 0.8× 150 3.7k
Zhanhong Wu United States 29 980 0.5× 687 0.7× 855 1.0× 228 0.3× 523 1.0× 79 3.1k
Thomas L. Mindt Switzerland 33 1.6k 0.8× 952 1.0× 1.0k 1.2× 392 0.5× 1.5k 3.1× 86 3.4k
Jan Mařı́k United States 30 1.3k 0.6× 671 0.7× 1.2k 1.4× 236 0.3× 459 0.9× 71 2.7k
C. Andrew Boswell United States 29 2.1k 1.0× 1.2k 1.3× 1.2k 1.4× 407 0.5× 189 0.4× 56 3.4k
Bart Cornelissen United Kingdom 29 1.1k 0.5× 948 1.0× 914 1.1× 410 0.5× 111 0.2× 112 2.5k
Johannes Notni Germany 32 1.6k 0.8× 929 1.0× 865 1.0× 472 0.6× 317 0.6× 83 3.2k
Sean Carlin United States 36 1.9k 0.9× 741 0.8× 1.1k 1.3× 659 0.8× 393 0.8× 100 3.7k

Countries citing papers authored by Carmen Wängler

Since Specialization
Citations

This map shows the geographic impact of Carmen Wängler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Wängler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Wängler more than expected).

Fields of papers citing papers by Carmen Wängler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Wängler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Wängler. The network helps show where Carmen Wängler may publish in the future.

Co-authorship network of co-authors of Carmen Wängler

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Wängler. A scholar is included among the top collaborators of Carmen Wängler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Wängler. Carmen Wängler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailey, Justin J., Melinda Wuest, Alexey Kostikov, et al.. (2025). Development and clinical potential of 18F-PSiMA for prostate cancer PET imaging. RSC Medicinal Chemistry. 16(8). 3633–3644. 1 indexed citations
2.
Sawall, Stefan, et al.. (2025). Development and characterization of new contrast agents for Photon-Counting CT. European Journal of Radiology. 195. 112643–112643.
3.
Wängler, Björn, et al.. (2025). α Emitter-Labeled Radiopeptides for Targeted α Therapy of Tumors. Journal of Medicinal Chemistry. 68(23). 24785–24805.
4.
Ebner, R., Nicola Fink, Matthias F. Froelich, et al.. (2025). Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE - impact on interdisciplinary communication. Scientific Reports. 15(1). 4793–4793.
5.
Wenter, Vera, Johannes Toms, Simon Lindner, et al.. (2024). PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 900–912. 5 indexed citations
7.
Wängler, Björn, et al.. (2024). Are 3D Tumor Cell Spheroids a Utile System for the In Vitro Evaluation of Diagnostic Radiotracers?. ACS Omega. 9(52). 51349–51362. 1 indexed citations
8.
Wängler, Carmen, et al.. (2023). CycloSiFA: The Next Generation of Silicon‐Based Fluoride Acceptors for Positron Emission Tomography (PET). Angewandte Chemie International Edition. 62(50). e202309002–e202309002. 3 indexed citations
10.
Wängler, Björn, et al.. (2023). Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11. Pharmaceuticals. 16(2). 273–273. 4 indexed citations
11.
Thiel, Alexander, Alexey Kostikov, Jean‐Paul Soucy, et al.. (2023). Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans. EJNMMI Radiopharmacy and Chemistry. 8(1). 33–33. 2 indexed citations
13.
Schirrmacher, Ralf, et al.. (2022). Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors. ACS Omega. 7(31). 27690–27702. 4 indexed citations
14.
Wängler, Carmen, Peter Bartenstein, Leonie Beyer, et al.. (2021). Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals. Pharmaceuticals. 14(7). 701–701. 17 indexed citations
15.
Bailey, Justin J., Melinda Wuest, Michael Wagner, et al.. (2021). Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model. Journal of Medicinal Chemistry. 64(21). 15671–15689. 10 indexed citations
16.
Bailey, Justin J., Melinda Wuest, Carmen Wängler, et al.. (2021). On the Viability of Tadalafil-Based 18F-Radiotracers for In Vivo Phosphodiesterase 5 (PDE5) PET Imaging. ACS Omega. 6(33). 21741–21754. 3 indexed citations
17.
Bailey, Justin J., Harun Ilhan, Peter Bartenstein, et al.. (2020). <sup>18</sup>F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography. Journal of Visualized Experiments. 2 indexed citations
18.
Bernard‐Gauthier, Vadim, Carmen Wängler, Esther Schirrmacher, et al.. (2014). 18F-Labeled Silicon-Based Fluoride Acceptors: Potential Opportunities for Novel Positron Emitting Radiopharmaceuticals. BioMed Research International. 2014. 1–20. 34 indexed citations
19.
Wängler, Carmen, Ralf Schirrmacher, Peter Bartenstein, & Björn Wängler. (2010). Click-Chemistry Reactions in Radiopharmaceutical Chemistry: Fast & Easy Introduction of Radiolabels into Biomolecules for In Vivo Imaging. Current Medicinal Chemistry. 17(11). 1092–1116. 94 indexed citations
20.
Wängler, Carmen, Martin Schäfer, Ralf Schirrmacher, Peter Bartenstein, & Björn Wängler. (2010). DOTA derivatives for site-specific biomolecule-modification via click chemistry: Synthesis and comparison of reaction characteristics. Bioorganic & Medicinal Chemistry. 19(12). 3864–3874. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026